These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6377886)

  • 1. Conceptual dilemmas in the classification of vasodilator drugs for severe chronic heart failure. Advocacy of a pragmatic approach to the selection of a therapeutic agent.
    Packer M
    Am J Med; 1984 Jun; 76(6A):3-13. PubMed ID: 6377886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects of vasodilators and long-term response in heart failure.
    Franciosa JA; Dunkman WB; Leddy CL
    J Am Coll Cardiol; 1984 Jun; 3(6):1521-30. PubMed ID: 6325522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs.
    Packer M; Medina N; Yushak M
    Am Heart J; 1982 Nov; 104(5 Pt 2):1215-23. PubMed ID: 6753552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of vasodilator drugs for patients with severe chronic heart failure: an approach based on a new classification.
    Packer M
    Drugs; 1982 Jul; 24(1):64-74. PubMed ID: 6125370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of captopril and isosorbide dinitrate on pulmonary arteriolar resistance and right ventricular function in patients with severe left ventricular failure: results of a randomized crossover study.
    Packer M; Medina N; Yushak M; Lee WH
    Am Heart J; 1985 Jun; 109(6):1293-9. PubMed ID: 3890506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure.
    Steimle AE; Stevenson LW; Chelimsky-Fallick C; Fonarow GC; Hamilton MA; Moriguchi JD; Kartashov A; Tillisch JH
    Circulation; 1997 Aug; 96(4):1165-72. PubMed ID: 9286945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilator therapy for chronic left ventricular failure.
    Kovick RB; Tillisch JH; Berens SC; Bramowitz AD; Shine KI
    Circulation; 1976 Feb; 53(2):322-8. PubMed ID: 812614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate.
    Williams DO; Bommer WJ; Miller RR; Amsterdam EA; Mason DT
    Am J Cardiol; 1977 Jan; 39(1):84-90. PubMed ID: 318795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vasodilator agents in the therapeutic arsenal of cardiac insufficiency].
    Lavitola Pde L; Higa SS
    Rev Paul Med; 1986; 104(3):136-40. PubMed ID: 3563266
    [No Abstract]   [Full Text] [Related]  

  • 10. New perspectives on therapeutic application of nitrates as vasodilator agents for severe chronic heart failure.
    Packer M
    Am J Med; 1983 Jun; 74(6B):61-72. PubMed ID: 6859073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination vasodilator therapy for severe chronic congestive heart failure.
    Chatterjee K; Drew D; Parmley WW; Klausner SC; Polansky J; Zacherle B
    Ann Intern Med; 1976 Oct; 85(4):467-70. PubMed ID: 823852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologic and pharmacologic determinants of vasodilator response: a conceptual framework for rational drug therapy for chronic heart failure.
    Packer M; Le Jemtel TH
    Prog Cardiovasc Dis; 1982; 24(4):275-92. PubMed ID: 7034047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of vasodilator therapy in the treatment of severe chronic heart failure.
    Packer M
    Drugs; 1986; 32 Suppl 5():13-26. PubMed ID: 3552590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vasodilator therapy in cardiac failure].
    Akatsuka N
    Nihon Rinsho; 1993 May; 51(5):1276-80. PubMed ID: 8101237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasodilator therapy for congestive heart failure--new use for old drugs.
    McAlpin RN
    JAMA; 1978 Aug; 240(5):461-2. PubMed ID: 660892
    [No Abstract]   [Full Text] [Related]  

  • 16. Results of long-term vasodilator therapy in patients with refractory congestive heart failure.
    Walsh WF; Greenberg BH
    Circulation; 1981 Sep; 64(3):499-505. PubMed ID: 7261282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilator therapy in chronic congestive heart failure.
    Schwartz AB; Chatterjee K
    Drugs; 1983 Aug; 26(2):148-73. PubMed ID: 6349967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of peripheral vasodilators on arrhythmia in patients with chronic coronary insufficiency].
    Mareev VIu; Kazeĭ DV; Ageev FT; Shevliagin SA; Grigor'iants RA
    Kardiologiia; 1992 Apr; 32(4):30-5. PubMed ID: 1405230
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemodynamic effects of vasodilator therapy in severe left heart failure combined with large atrial septal defects.
    Kolibash AJ; Magorien RD; Robinson JL; Leier CV
    Am J Med; 1982 Sep; 73(3):439-4. PubMed ID: 7124771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.